Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Lung Cancer

  Free Subscription


Articles published in Mol Carcinog

Retrieve available abstracts of 44 articles:
HTML format
Text format



Single Articles


    October 2019
  1. TSUBOI M, Kondo K, Soejima S, Kajiura K, et al
    Chromate exposure induces DNA hypermethylation of the mismatch repair gene MLH1 in lung cancer.
    Mol Carcinog. 2019 Oct 3. doi: 10.1002/mc.23125.
    PubMed     Text format     Abstract available


    September 2019
  2. SUN W, Hu S, Zu Y, Deng Y, et al
    KLF3 is a crucial regulator of metastasis by controlling STAT3 expression in lung cancer.
    Mol Carcinog. 2019 Sep 5. doi: 10.1002/mc.23072.
    PubMed     Text format     Abstract available


    August 2019
  3. CUI J, Yin Z, Liu G, Chen X, et al
    Activating transcription factor 1 promoted migration and invasion in lung cancer cells through regulating EGFR and MMP-2.
    Mol Carcinog. 2019 Aug 16. doi: 10.1002/mc.23086.
    PubMed     Text format     Abstract available


  4. FU Y, Su L, Cai M, Yao B, et al
    Downregulation of CPA4 inhibits non small-cell lung cancer growth by suppressing the AKT/c-MYC pathway.
    Mol Carcinog. 2019 Aug 9. doi: 10.1002/mc.23095.
    PubMed     Text format     Abstract available


    May 2019
  5. XU L, Qiu S, Yang L, Xu H, et al
    Aminocyanopyridines as anti-lung cancer agents by inhibiting the STAT3 pathway.
    Mol Carcinog. 2019 May 8. doi: 10.1002/mc.23038.
    PubMed     Text format     Abstract available


  6. MA W, Ho DW, Sze KM, Tsui YM, et al
    APOBEC3B promotes hepatocarcinogenesis and metastasis through novel deaminase-independent activity.
    Mol Carcinog. 2019;58:643-653.
    PubMed     Text format     Abstract available


    April 2019
  7. SUN Q, Wang Y, Fan J, Li Z, et al
    Association of expression quantitative trait loci for long noncoding RNAs with lung cancer risk in Asians.
    Mol Carcinog. 2019 Apr 26. doi: 10.1002/mc.23013.
    PubMed     Text format     Abstract available


  8. GUO Y, Feng Y, Liu H, Luo S, et al
    Potentially functional genetic variants in the TNF/TNFR signaling pathway genes predict survival of patients with non-small cell lung cancer in the PLCO cancer screening trial.
    Mol Carcinog. 2019 Apr 15. doi: 10.1002/mc.23017.
    PubMed     Text format     Abstract available


    March 2019
  9. YOO SM, Lee CJ, Kang HC, Lee HS, et al
    Epimagnolin targeting on an active pocket of mammalian target of rapamycin suppressed cell transformation and colony growth of lung cancer cells.
    Mol Carcinog. 2019 Mar 18. doi: 10.1002/mc.23005.
    PubMed     Text format     Abstract available


  10. HAN X, Dong Q, Wu J, Luo Y, et al
    RASSF10 suppresses lung cancer proliferation and invasion by decreasing the level of phosphorylated LRP6.
    Mol Carcinog. 2019 Mar 4. doi: 10.1002/mc.23000.
    PubMed     Text format     Abstract available


  11. LAWSON J, Dickman C, Towle R, Jabalee J, et al
    Extracellular vesicle secretion of miR-142-3p from lung adenocarcinoma cells induces tumor promoting changes in the stroma through cell-cell communication.
    Mol Carcinog. 2019;58:376-387.
    PubMed     Text format     Abstract available


    February 2019
  12. DING Z, Zhu J, Zeng Y, Du W, et al
    The regulation of Neuropilin 1 expression by miR-338-3p promotes non-small cell lung cancer via changes in EGFR signaling.
    Mol Carcinog. 2019 Feb 27. doi: 10.1002/mc.22990.
    PubMed     Text format     Abstract available


  13. CHEN W, Do KC, Saxton B, Leng S, et al
    Inhibition of the hexosamine biosynthesis pathway potentiates cisplatin cytotoxicity by decreasing BiP expression in non-small cell lung cancer cells.
    Mol Carcinog. 2019 Feb 20. doi: 10.1002/mc.22992.
    PubMed     Text format     Abstract available


  14. SUMARDIKA IW, Chen Y, Tomonobu N, Kinoshita R, et al
    NEUROPLASTIN-beta MEDIATES S100A8/A9-INDUCED LUNG CANCER DISSEMINATIVE PROGRESSION.
    Mol Carcinog. 2019 Feb 5. doi: 10.1002/mc.22987.
    PubMed     Text format     Abstract available


  15. LI X, Fu Q, Zhu Y, Wang J, et al
    CD147-mediated glucose metabolic regulation contributes to the predictive role of (18) F-FDG PET/CT imaging for EGFR-TKI treatment sensitivity in NSCLC.
    Mol Carcinog. 2019;58:247-257.
    PubMed     Text format     Abstract available


    January 2019
  16. LI Y, Xiang C, Shen N, Deng L, et al
    Functional polymorphisms on chromosome 5p15.33 disturb telomere biology and confer the risk of non-small cell lung cancer in Chinese population.
    Mol Carcinog. 2019 Jan 25. doi: 10.1002/mc.22980.
    PubMed     Text format     Abstract available


  17. ZHANG X, Han S, Zhou H, Cai L, et al
    TIMM50 promotes tumor progression via ERK signaling and predicts poor prognosis of non-small cell lung cancer patients.
    Mol Carcinog. 2019 Jan 3. doi: 10.1002/mc.22969.
    PubMed     Text format     Abstract available


    December 2018
  18. LIU WB, Han F, Huang YS, Chen HQ, et al
    TMEM196 hypermethylation as a novel diagnostic and prognostic biomarker for lung cancer.
    Mol Carcinog. 2018 Dec 11. doi: 10.1002/mc.22942.
    PubMed     Text format     Abstract available


    October 2018
  19. SONG JM, Im J, Nho RS, Han YH, et al
    Hyaluronan-CD44/RHAMM interaction-dependent cell proliferation and survival in lung cancer cells.
    Mol Carcinog. 2018 Oct 26. doi: 10.1002/mc.22930.
    PubMed     Text format     Abstract available


  20. JIAN M, Yunjia Z, Zhiying D, Yanduo J, et al
    Interleukin 7 Receptor Activates PI3K/Akt/mTOR Signaling Pathway via Downregulation of Beclin-1 in Lung Cancer.
    Mol Carcinog. 2018 Oct 26. doi: 10.1002/mc.22933.
    PubMed     Text format     Abstract available


    September 2018
  21. FENG Y, Gao Y, Yu J, Jiang G, et al
    CCDC85B promotes non-small cell lung cancer cell proliferation and invasion.
    Mol Carcinog. 2018 Sep 22. doi: 10.1002/mc.22914.
    PubMed     Text format     Abstract available


    August 2018
  22. CHEN QY, Li J, Sun H, Wu F, et al
    Role of miR-31 and SATB2 in arsenic-induced malignant BEAS-2B cell transformation.
    Mol Carcinog. 2018;57:968-977.
    PubMed     Text format     Abstract available


    June 2018
  23. WU GJ, Pen J, Huang Y, An S, et al
    KAP1 inhibits the Raf-MEK-ERK pathway to promote tumorigenesis in A549 lung cancer cells.
    Mol Carcinog. 2018 Jun 19. doi: 10.1002/mc.22853.
    PubMed     Text format     Abstract available


  24. BORREGO A, Cabrera WHK, Jensen JR, Correa M, et al
    Germline control of somatic Kras mutations in mouse lung tumors.
    Mol Carcinog. 2018;57:745-751.
    PubMed     Text format     Abstract available


    May 2018
  25. LI Z, Fan J, Li N, Zhu M, et al
    Fine mapping in TERT-CLPTM1L region identified three independent lung cancer susceptibility signals: a large-scale multi-ethnic population study.
    Mol Carcinog. 2018 May 29. doi: 10.1002/mc.22843.
    PubMed     Text format     Abstract available


  26. WANG S, Cheng Y, Gao Y, He Z, et al
    SH2B1 promotes epithelial-mesenchymal transition through the IRS1/beta-catenin signaling axis in lung adenocarcinoma.
    Mol Carcinog. 2018;57:640-652.
    PubMed     Text format     Abstract available


    March 2018
  27. YANG Y, Sun Y, Wu Y, Tang D, et al
    Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/beta-catenin signaling in non-small-cell lung cancer.
    Mol Carcinog. 2018 Mar 22. doi: 10.1002/mc.22805.
    PubMed     Text format     Abstract available


    January 2018
  28. SU YC, Chang H, Sun SJ, Liao C, et al
    Differential Impact of CX3CL1 on Lung Cancer Prognosis in Smokers and Non-smokers.
    Mol Carcinog. 2018 Jan 30. doi: 10.1002/mc.22787.
    PubMed     Text format     Abstract available


    December 2017
  29. WANG H, Wang L, Cao L, Zhang Q, et al
    Inhibition of autophagy potentiates the anti-metastasis effect of phenethyl isothiocyanate through JAK2/STAT3 pathway in lung cancer cells.
    Mol Carcinog. 2017 Dec 26. doi: 10.1002/mc.22777.
    PubMed     Text format     Abstract available


    November 2017
  30. YANG L, Lin Z, Wang Y, Gao S, et al
    MiR-5100 increases the cisplatin resistance of the lung cancer stem cells by inhibiting the Rab6.
    Mol Carcinog. 2017 Nov 16. doi: 10.1002/mc.22765.
    PubMed     Text format     Abstract available


    October 2017
  31. FENG Y, Wang Y, Liu H, Liu Z, et al
    Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer.
    Mol Carcinog. 2017 Oct 26. doi: 10.1002/mc.22748.
    PubMed     Text format     Abstract available


  32. PAN Z, Liu L, Nie W, Miggin S, et al
    Long non-coding RNA AGER-1 functionally upregulates the innate immunity gene AGER and approximates its anti-tumor effect in lung cancer.
    Mol Carcinog. 2017 Oct 25. doi: 10.1002/mc.22756.
    PubMed     Text format     Abstract available


  33. TAO S, de la Vega MR, Chapman E, Ooi A, et al
    The effects of NRF2 modulation on the initiation and progression of chemically and genetically induced lung cancer.
    Mol Carcinog. 2017 Oct 4. doi: 10.1002/mc.22745.
    PubMed     Text format     Abstract available


    September 2017
  34. LI Y, Zhang H, Li Y, Zhao C, et al
    MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene.
    Mol Carcinog. 2017 Sep 21. doi: 10.1002/mc.22741.
    PubMed     Text format     Abstract available


  35. HAN Y, Tang Z, Zhao Y, Li Q, et al
    TNFAIP8 regulates Hippo pathway through interacting with LATS1 to promote cell proliferation and invasion in lung cancer.
    Mol Carcinog. 2017 Sep 19. doi: 10.1002/mc.22740.
    PubMed     Text format     Abstract available


  36. ZHAO H, Zhang D, Yang L, Wang E, et al
    p0071 interacts with E-cadherin in the cytoplasm so as to promote the invasion and metastasis of non-small cell lung cancer.
    Mol Carcinog. 2017 Sep 12. doi: 10.1002/mc.22734.
    PubMed     Text format     Abstract available


    July 2017
  37. ZHANG X, Cai L, Zhou H, Liu Y, et al
    Lasp2 enhances tumor invasion via facilitating phosphorylation of FAK and predicts poor overall survival of non-small cell lung cancer patients.
    Mol Carcinog. 2017 Jul 1. doi: 10.1002/mc.22700.
    PubMed     Text format     Abstract available


  38. YOU BR, Park WH
    Suberoylanilide hydroxamic acid induces thioredoxin1-mediated apoptosis in lung cancer cells via up-regulation of miR-129-5p.
    Mol Carcinog. 2017 Jul 1. doi: 10.1002/mc.22701.
    PubMed     Text format     Abstract available


    May 2017
  39. ZHU X, Li D, Zhang Z, Zhu W, et al
    Persistent phosphorylation at specific H3 serine residues involved in chemical carcinogen-induced cell transformation.
    Mol Carcinog. 2017;56:1449-1460.
    PubMed     Text format     Abstract available


    April 2017
  40. ERDEM JS, Arnoldussen YJ, Skaug V, Haugen A, et al
    Copy number variation, increased gene expression and molecular mechanisms of Neurofascin in lung cancer.
    Mol Carcinog. 2017 Apr 18. doi: 10.1002/mc.22664.
    PubMed     Text format     Abstract available


  41. ZHOU C, Chen T, Xie Z, Qin Y, et al
    RACK1 Forms a Complex with FGFR1 and PKM2 and Stimulates the Growth and Migration of Squamous Lung Cancer Cells.
    Mol Carcinog. 2017 Apr 18. doi: 10.1002/mc.22663.
    PubMed     Text format     Abstract available


  42. XIE M, Wu X, Zhang J, Zhang J, et al
    Ski regulates Smads and TAZ signaling to suppress lung cancer progression.
    Mol Carcinog. 2017 Apr 11. doi: 10.1002/mc.22661.
    PubMed     Text format     Abstract available


  43. ZHANG X, Zhou H, Cai L, Fan C, et al
    Kctd20 promotes the development of non-small cell lung cancer through activating Fak/AKT pathway and predicts poor overall survival of patients.
    Mol Carcinog. 2017 Apr 11. doi: 10.1002/mc.22660.
    PubMed     Text format     Abstract available


    March 2017
  44. CHAE DK, Ban E, Yoo YS, Kim EE, et al
    MIR-27a regulates the TGF-beta signaling pathway by targeting SMAD2 and SMAD4 in lung cancer.
    Mol Carcinog. 2017 Mar 31. doi: 10.1002/mc.22655.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: